
The label says 'CBD' — but which CBD? Full spectrum, broad spectrum, and isolate are three fundamentally different products that share a name but differ significantly in composition, effectiveness, and risk profile. Getting this choice wrong is one of the most common mistakes first-time CBD buyers make.
The differences aren't just marketing language. They reflect real chemistry: how many of hemp's hundreds of active compounds are present in your product, whether any THC is included, and whether the compounds work together to produce the synergistic effect researchers call the entourage effect. For some people, this choice determines whether CBD works at all. For others — particularly drug-tested athletes and seniors on medications — it determines whether CBD is safe.
This guide covers all three types with precision. For related buyer guide topics, seeCBD Oil vs. Gummies vs. Capsules: Which Is Right for You?,How to Read a CBD Lab Report (COA), andNano CBD: What It Is and Why It Actually Matters.
Hemp contains hundreds of biologically active compounds — not just CBD. Understanding what's in the plant is the foundation for understanding what each product type does and doesn't include.
Full spectrum extract contains the complete cannabinoid and terpene profile of the hemp plant — including up to 0.3% THC, all minor cannabinoids (CBG, CBN, CBC, etc.), the full terpene profile, and flavonoids. It is the least processed of the three types — the goal is to preserve as much of the original plant chemistry as possible.
What 0.3% THC actually means in practice:A 1000mg CBD oil bottle might contain 3mg of THC total. A single 25mg serving would contain approximately 0.075mg of THC — well below any psychoactive threshold for a single dose. However, daily use accumulates: THC is fat-soluble and stores in adipose tissue. Over weeks of consistent use, trace THC can build to detectable levels in a drug test — particularly at the lower thresholds used by WADA and NCAA (10–15 ng/mL urine). This is the practical risk for drug-tested users, not any single-dose intoxication concern.
Broad spectrum extract undergoes an additional processing step to remove all THC while retaining the full complement of other cannabinoids, terpenes, and flavonoids. The goal is to preserve the entourage effect as completely as possible while eliminating the THC variable entirely.
Quality broad spectrum products achieve non-detectable THC (listed as 'ND' or '<LOQ' on a Certificate of Analysis) — meaning the THC content is below the limit the lab can reliably measure, which is functionally zero for both psychoactive and drug-test purposes. PureCraft uses broad-spectrum in all products, with COA-verified non-detectable THC across every batch.
CBD isolate is pure CBD — typically 99%+ purity — with all other cannabinoids, terpenes, and plant compounds removed. It's the most refined form, produced through additional extraction and purification processes that leave only the CBD molecule. Isolate is typically a white crystalline powder that can be added to oils, gummies, or other products.
CBD isolate is the simplest product to verify — a COA for isolate should show CBD purity of 99%+, zero THC, and no other compounds. What it won't show is the entourage-effect synergy that makes full and broad spectrum products more therapeutically potent per milligram.
|
|
Full Spectrum |
Broad Spectrum |
CBD Isolate |
|
THC content |
Up to 0.3% (legal limit) |
Non-detectable (0.00%) |
Zero |
|
CBD content |
Present |
Present |
Pure CBD only (99%+) |
|
Other cannabinoids (CBG, CBN, CBC, etc.) |
Yes — full plant profile |
Yes — THC removed |
No |
|
Terpenes |
Yes — full plant terpene profile |
Yes — most preserved |
No |
|
Entourage effect |
✓ Maximum |
✓ Strong (minus THC) |
✗ None |
|
Psychoactive risk |
Very low, but non-zero |
None |
None |
|
Drug test risk |
Low-moderate (THC can accumulate) |
Negligible (zero THC) |
Negligible |
|
Legal in all 50 states |
✓ Yes (hemp-derived, <0.3% THC) |
✓ Yes |
✓ Yes |
|
Best for |
Maximum entourage effect; legal states with no testing |
Most users — full benefit, zero THC risk |
THC sensitivity; very strict testing environments |
|
Therapeutic potency |
Highest (with THC synergy) |
High (near-equivalent without THC) |
Lowest per mg of CBD |
|
PureCraft choice |
— |
✓ All PureCraft products |
— |
The entourage effect is the central argument for full and broad spectrum over isolate — and it's not marketing language. It refers to the well-documented phenomenon where cannabinoids, terpenes, and other hemp compounds work synergistically, producing effects that are greater than the sum of their individual parts.
The entourage effect was first formally described by Israeli researchers Raphael Mechoulam and Shimon Ben-Shabat in 1998, noting that endocannabinoids produced stronger effects in the presence of inactive related compounds. The concept was extended to cannabis by Ethan Russo in alandmark 2011 paper in the British Journal of Pharmacology that documented how terpenes modulate cannabinoid receptor activity and potentially enhance the therapeutic effects of CBD and other cannabinoids.
A direct comparison study supporting the entourage effect came from a2015 study in Pharmacology & Pharmacy that examined CBD isolate versus a whole-plant CBD-rich extract in an inflammatory model. The whole-plant extract produced a more complete, dose-responsive effect — meaning higher doses produced proportionally greater benefit. CBD isolate, by contrast, showed a bell-shaped dose-response curve, becoming less effective at higher doses. This finding has significant practical implications: with isolate, more is not necessarily better; with whole-plant extracts, the dose-response relationship is more predictable and reliable.
The mechanisms of entourage synergy operate at multiple levels:
Beyond CBD, here's what the minor cannabinoids in full and broad spectrum products contribute:
|
Cannabinoid |
Found In |
Primary Properties |
Relevant For |
|
CBD (Cannabidiol) |
All three types |
Anti-inflammatory, anxiolytic, analgesic, neuroprotective |
Pain, anxiety, sleep, inflammation — the foundation |
|
THC (Tetrahydrocannabinol) |
Full spectrum only |
Psychoactive, analgesic, appetite stimulating, sleep-promoting |
Pain amplification with CBD; sleep; appetite |
|
CBG (Cannabigerol) |
Full & broad spectrum |
Anti-inflammatory, antibacterial, neuroprotective, mood support |
Pain, inflammation, focus, gut health |
|
CBN (Cannabinol) |
Full & broad spectrum |
Mildly sedative, anti-inflammatory, appetite stimulating |
Sleep support — most significant minor cannabinoid for this |
|
CBC (Cannabichromene) |
Full & broad spectrum |
Anti-inflammatory, antidepressant, neurogenesis support |
Pain, mood, neuroprotection |
|
CBDV (Cannabidivarin) |
Full & broad spectrum |
Anti-seizure, anti-nausea, reduces inflammation |
Neurological conditions, GI distress |
|
THCV (trace) |
Full spectrum (trace) |
Appetite suppressant, may modulate THC effects |
Trace amounts — minimal effect at these levels |
Why CBN matters specifically:Among the minor cannabinoids, CBN (cannabinol) has the most established individual therapeutic profile for common wellness applications — particularly sleep. PureCraft'sCBD+CBN Sleep Gummiesspecifically leverage this by combining CBD with elevated CBN alongside melatonin, targeting the hyperarousal and sleep architecture disruption most responsible for insomnia.
For the overwhelming majority of CBD users — people seeking relief from pain, anxiety, sleep issues, inflammation, or general wellness — broad spectrum is the optimal choice. It delivers the full entourage effect without any THC-related risks. The processing step that removes THC has minimal impact on the other cannabinoids and terpenes, so the therapeutic profile is close to full spectrum in practice.
Broad spectrum is specifically the right choice for:
PureCraft's position:All PureCraft products are broad spectrum with COA-verified non-detectable THC — providing the entourage effect at maximum bioavailability without any THC compromise.
Full spectrum may offer a marginal additional therapeutic benefit for conditions where THC's analgesic and sedative properties contribute meaningfully alongside CBD — particularly severe chronic pain, cancer-related pain, and severe sleep disorders. The difference in practice between high-quality broad spectrum and full spectrum is modest for most users.
Full spectrum is appropriate when:
The honest trade-off:The marginal benefit of trace THC over high-quality broad spectrum is small. The risks — drug test failure for athletes, adverse effects in THC-sensitive individuals, cardiovascular effects in seniors — are real. For most users, broad spectrum is the better risk-adjusted choice.
CBD isolate's primary advantage is simplicity and predictability. The exact CBD content is easy to verify, there's no THC under any circumstances, and there are no terpenes or other compounds to account for. For researchers studying isolated CBD effects, or for individuals with documented sensitivities to terpenes, isolate has a role.
For general wellness use, isolate is the weakest therapeutic option. The bell-shaped dose-response curve documented in the 2015 research, the absence of entourage synergy, and the inability to leverage minor cannabinoids for specific applications (CBN for sleep, CBG for focus) all work against it as a first-choice product. Most users who've tried both broad spectrum and isolate at equivalent doses report that broad spectrum produces more noticeable effects.
Labels can be misleading — 'full spectrum,' 'broad spectrum,' and 'isolate' are not legally standardized terms in the supplement industry. The only reliable verification is the Certificate of Analysis (COA) from an independent third-party laboratory.
For a step-by-step guide to reading a COA, see our dedicated guide:How to Read a CBD Lab Report (COA): A Beginner's Guide.
With COA-verified non-detectable THC, the risk of a positive drug test from broad spectrum CBD is negligible. The test is looking for THC metabolites — and if there is no THC, there are no THC metabolites to detect. PureCraft's broad spectrum products have non-detectable THC confirmed by third-party testing on every batch. The risk is not zero in theory (trace contamination is always possible in manufacturing), but it is extremely low with verified products.
Yes — the 2015 Pharmacology & Pharmacy comparison study showed a meaningful difference in dose-response between whole-plant extract and isolate, with the whole-plant extract producing more consistent, predictable, and dose-responsive effects. Most practitioners who use CBD therapeutically recommend full or broad spectrum over isolate for this reason. The difference is most pronounced for chronic conditions requiring consistent daily use.
Hemp-derived full spectrum CBD with less than 0.3% THC is federally legal in the United States under the 2018 Farm Bill. It is legal in most US states. However, some states have additional restrictions on THC content — check your specific state law if you have concerns. PureCraft's products are all broad spectrum and compliant in all 50 states.
At the 0.3% legal limit in hemp products, a typical serving contains approximately 0.075–0.15mg of THC — far below the threshold required for psychoactive effects (typically 2–5mg minimum for most people). The vast majority of full spectrum hemp product users report no psychoactive effect whatsoever. The concern with full spectrum is drug test accumulation over time, not single-dose intoxication.
PureCraft's customers span a wide range of situations — drug-tested athletes, seniors on medications, parents, professionals in zero-tolerance environments. Full spectrum's trace THC introduces a variable that isn't appropriate for all of these users. Broad spectrum provides the same entourage effect benefits as full spectrum for the vast majority of therapeutic applications, while eliminating the THC risk that matters to a significant portion of the user base. Combined with PureCraft's nanotechnology, broad spectrum at high bioavailability outperforms conventional full spectrum at low bioavailability — which is the actual performance benchmark that matters.
For most people, broad spectrum is the right answer — it delivers the full entourage effect, eliminates THC risk, and is appropriate across the widest range of user situations. Full spectrum offers a marginal additional benefit for severe pain or sleep applications in users not subject to drug testing. Isolate is the weakest therapeutic option and appropriate only in narrow circumstances.
The more important variable isn't which spectrum type — it's product quality. A high-quality nano-optimized broad spectrum will outperform a low-quality full spectrum every time. Verify the COA, confirm non-detectable THC on broad spectrum products, and choose a brand that publishes its testing transparently.
All PureCraft products are broad spectrum with COA-verified non-detectable THC, nano-optimized for up to 90% bioavailability, and made from 100% USA-grown hemp.View the full product lineup — including CBD oils, gummies, sleep gummies, and topicals — all built to the standard that makes spectrum type a meaningful choice rather than a marketing label.
A Certificate of Analysis (COA) is the single most important document in CBD. It's what separates verified, trustworthy products from the vast num...
Read More
Medical Disclaimer | This article is for informational and educational purposes only. CBD is not a substitute for professional medical evaluation ...
Read More
Medical Disclaimer | This article is for informational and educational purposes only. CBD is not a substitute for professional medical evaluation ...
Read More